Immune microenvironment composition in non‐small cell lung cancer and its association with survival

by Menno Tamminga, Thijo Jeroen N Hiltermann, Ed Schuuring, Wim Timens, Rudolf SN Fehrmann, Harry JM Groen
Published 2020-01-01

Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors

by Menno Tamminga, Sanne de Wit, T. Jeroen N. Hiltermann, Wim Timens, Ed Schuuring, Leon W. M. M. Terstappen, Harry J. M. Groen
Published 2019-07-01

Classification of Cells in CTC-Enriched Samples by Advanced Image Analysis

by Sanne de Wit, Leonie L. Zeune, T. Jeroen N. Hiltermann, Harry J. M. Groen, Guus van Dalum, Leon W. M. M. Terstappen
Published 2018-10-01

Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-PD-L1 Immune Checkpoint Inhibitor

by Sarah Pringle, Bert van der Vegt, Xiaoyan Wang, Nico van Bakelen, T. Jeroen N. Hiltermann, Fred K. L. Spijkervet, Arjan Vissink, Frans G. M. Kroese, Hendrika Bootsma
Published 2020-04-01

Mutations in EMT-Related Genes in ALK Positive Crizotinib Resistant Non-Small Cell Lung Cancers

by Jiacong Wei, Anthonie J. van der Wekken, Ali Saber, Miente M. Terpstra, Ed Schuuring, Wim Timens, T. Jeroen N. Hiltermann, Harry J. M. Groen, Anke van den Berg, Klaas Kok
Published 2018-01-01

Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer.

by Ali Saber, Anthonie J van der Wekken, Gerald S M A Kerner, Maarten van den Berge, Wim Timens, Ed Schuuring, Arja ter Elst, Anke van den Berg, T Jeroen N Hiltermann, Harry J M Groen
Published 2016-01-01

Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing.

by Ali Saber, Anthonie J van der Wekken, Klaas Kok, M Martijn Terpstra, Lisette J Bosman, Mirjam F Mastik, Wim Timens, Ed Schuuring, T Jeroen N Hiltermann, Harry J M Groen, Anke van den Berg
Published 2016-01-01

Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch^® and ISET

by Menno Tamminga, Kiki C. Andree, T. Jeroen N. Hiltermann, Maximilien Jayat, Ed Schuuring, Hilda van den Bos, Diana C. J. Spierings, Peter M. Lansdorp, Wim Timens, Leon W. M. M. Terstappen, Harry J. M. Groen
Published 2020-04-01

An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients

by Jiacong Wei, Anna A. Rybczynska, Pei Meng, Martijn Terpstra, Ali Saber, Jantine Sietzema, Wim Timens, Ed Schuuring, T. Jeroen N. Hiltermann, Harry. J.M. Groen, Anthonie J. van der Wekken, Anke van den Berg, Klaas Kok
Published 2020-10-01

Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity

by Daan van den Broek, T. Jeroen N. Hiltermann, Bonne Biesma, Winand N. M. Dinjens, Nils A. 't Hart, John W. J. Hinrichs, John W. J. Hinrichs, Mathie P. G. Leers, Kim Monkhorst, Matthijs van Oosterhout, Volkher Scharnhorst, Ed Schuuring, Ernst-Jan M. Speel, Michel M. van den Heuvel, Ron H. N. van Schaik, Jan von der Thüsen, Stefan M. Willems, Leonie de Visser, Marjolijn J. L. Ligtenberg, Marjolijn J. L. Ligtenberg
Published 2020-01-01